Table 1 - uploaded by Ibrahim Abdelkader Salama
Content may be subject to copyright.
Source publication
Background: Ecchinococcal disease is still a serious problem in certain parts of the world, with liver as the most affected organ. Surgery remains the mainstay of treatment of hydatidosis, but the optimal surgical procedure remains unsettled. Objective: Safety and efficacy of major hepatic resection in multiple and giant hepatic hydatidosis. Patien...
Context in source publication
Similar publications
Aim of the study:
Our aim was to propose and examine the outcomes of a comprehensive strategy for the management of cystic liver hydatidosis (CLH) based on extensive intraoperative assessments and optimal management of cystobiliary communications.
Background data:
Although operative intervention remains the preferred treatment for CLH, and the p...
RESUMEN: Se comunica un caso de recidiva quiste hidatico de higado complicado con fistula bilio-quistica amplia , su evaluacion preoperatoria y el procedimiento quirurgico realizado; consistente en una quistoadeventicectomia cxasi total con desconexion quisto biliar con tubo de Kehr.
ABSTRACT: A recurrent case of liver hydatic cyst complicated with...
Management option of hepatic echinococcosis represents a major challenge for a surgeon. The aim of the study was to evaluate surgical treatment of patients with hepatic echinococcosis at the surgery department of the regional hospital in Prizren (Kosovo). The medical records of 22 patients operated for hepatic echinococcosis in our department durin...
Citations
... A total of 14 studies with 1,557 patients were included in the analysis. [9][10][11][12][13][19][20][21][22][23][24][25][26][27] Thirteen studies were designed retrospectively with three of them done on a prospectively maintained database, and there was one prospectively designed study. Eleven studies had less than 100 patients, which is an important source of bias. ...
... The study by Velazquez, which included only nine patients, had a major complication rate of 33%, 19 while the other two Qiu et al. 17% and Salama 15%, respectively. 10,26 All fourteen studies reported on the postoperative 30day mortality, which was nil for all studies except for the two mortalities in the series by Miura,13 which is the only multi-institutional as well as second largest series with a total of 241 patients. The cause of mortality in individual case was not mentioned by the author. ...
... Lack of a definition of giant hemangioma leads to a wide range of tumor size including any tumor above 4 cm, which in turn requires a wide range of surgical procedures from simple enucleations of 1 or many liver hemangiomas per surgery to major liver resections and also a liver transplant in one of the series. 26 Another important limitation is that although we have focussed upon the last 6 years literature on the topic, the study period of many of the papers went back to as long as 15 years which can potentially effect our understanding of recent trends in the management. ...
Objective:
To conduct a meta-analysis of reported evidence on surgical management for symptomatic giant liver hemangiomas.
Methodology:
A systematic literature search was conducted to identify studies on adult patient surgeries for symptomatic giant liver hemangiomas from January 2009 to July 2015. The primary outcome measures included postoperative symptom resolution, mortality, complications, and blood transfusions. Quality of life after surgery was taken as a secondary outcome. Meta-analysis was performed using a random-effect model with comprehensive meta-analysis software.
Results:
Fourteen studies with 1,557 patients were included. There were only two mortalities. Overall event rate for minor and major complications was low as 0.15 and 0.14, respectively, with a high symptom resolution rate of 0.69 (95%, CI 0.64-0.73). Pooled analysis for blood transfusion stayed insignificant due to high calculated heterogeneity across studies. Quality of life results after surgery are reported good by three studies, in most of their patients. The adverse outcome rate between enucleation and resection was comparable.
Conclusion:
Liver hemangioma surgery is a safe treatment option with negligible mortality and low morbidity. It is effective in terms of symptom control and overall quality of life.
